. Author manuscript; available in PMC: 2009 Jun 2.

Published in final edited form as: Psychopharmacology (Berl). 2007 Jul 10;194(4):505–515. doi: 10.1007/s00213-007-0861-5

Table 1.

Demographic characteristics of 36 adult male cannabis smokers according to treatment group

		Rimonabant dose group
		40 mg	90 mg	Placebo
N		12	12	12
Age (years)	Mean	28.6	30.6	27.6
	SD	6.7	6.9	5.4
Weight (kg)	Mean	80.2	73.7	75.3
	SD	17.0	12.7	10.3
Height (cm)	Mean	175.4	169.5	178.8
	SD	8.7	20.6	5.8
BMI (kg/m²)	Mean	25.8	27.0	23.5
	SD	3.2	10.7	2.4
Cannabis use in 30 days before screening (days)	Mean	20.9	23.5	16.5
Cannabis use in 30 days before screening (days)	SD	11.1	9.4	7.6
Lifetime cannabis use (years)	Mean	10.8	12.3	8.5
	SD	9.0	7.4	5.4
Race	White	3	3	6
	African-American	9	9	6

There were no significant group differences in age, weight, height, BMI, cannabis use in the 30 days before screening, lifetime cannabis use, or race.